What the TREAT Trial Actually Found About Time-Restricted Eating
Key finding
Over 12 weeks, 16:8 time-restricted eating produced no statistically significant weight-loss advantage over a standard three-meals-a-day pattern, once the modest calorie reduction that occurred naturally in the time-restricted group was accounted for.
Not medical advice — general information based on published research.Full disclaimer →

This trial randomised 116 adults with overweight or obesity to either eat only between 12pm and 8pm each day, or to eat three structured meals across a normal day, without giving either group an explicit calorie target. The point was to isolate the effect of the eating *window* itself from the effect of simply eating less.
Intermittent fasting has a large and growing body of research behind it, but a lot of the strongest mechanistic claims come from animal studies or short uncontrolled human observations. The TREAT trial is one of the more carefully designed human tests of the specific, popular 16:8 protocol.
What the researchers actually did
Lowe and colleagues randomised 116 adults with overweight or obesity into two groups [1]: one following 16:8 time-restricted eating (all calories consumed between 12pm and 8pm), the other eating three structured meals spread across a normal day. Neither group was given an explicit calorie target — the design specifically isolated “does the eating window itself matter” from “does eating less matter,” by not telling either group to restrict calories directly.
What it found
After 12 weeks, the time-restricted group lost slightly more weight on average than the standard-meal-pattern group, but the difference was not statistically significant. Looking at the food-logging data, the time-restricted group had simply, and apparently without deliberately trying, eaten somewhat fewer calories overall — a plausible side effect of shrinking the total time available to eat, rather than evidence of a separate metabolic mechanism.
Why it matters
This trial is a good instance of “well-designed study tests a popular, specific claim directly, and the claim doesn’t hold up as strongly as marketing suggests.” A broader review of intermittent fasting research [2] covers other mechanisms (ketone production, insulin sensitivity, cellular repair processes) that may matter over longer or more restrictive fasting windows than 16:8 — so this trial doesn’t close the book on intermittent fasting broadly. It does specifically weaken the claim that a standard 16:8 window has a metabolic edge over calorie intake alone.
Why it matters
Time-restricted eating is often marketed as having a metabolic advantage independent of calorie intake. This is one of the better-designed trials to actually test that specific claim, and it found the advantage — if any — was small and not statistically significant, with the modest weight difference tracking mostly with reduced calorie intake in the time-restricted group rather than a distinct metabolic effect of the eating window.
What this study doesn’t tell us
- 12 weeks is a relatively short trial duration for weight-management research — longer-term adherence and outcomes weren't measured here.
- The sample (116 participants) is a meaningful, well-designed trial but still a single study; it doesn't overrule the entire body of intermittent-fasting research, some of which points to other physiological effects during longer or more restrictive fasting protocols not tested here.
- Participants self-selected into a fasting-research study, which may not perfectly represent how time-restricted eating performs in a general population outside a trial context.
Sources cited
- [1]Lowe DA, Wu N, Rohdin-Bibby L, et al. (2020). Effects of Time-Restricted Eating on Weight Loss and Other Metabolic Parameters in Women and Men With Overweight and Obesity: The TREAT Randomized Clinical Trial . JAMA Internal Medicine.Single RCT
- [2]de Cabo R, Mattson MP (2019). Effects of Intermittent Fasting on Health, Aging, and Disease . The New England Journal of Medicine.Guideline


